Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α regimens for early chronic phase

Hagop Kantarjian, Susan O'Brien, Jorges Cortes, Jianqin Shan, Francis Giles, Guillermo Garcia-Manero, Srdan Verstovsek, Stefan Faderl, Mary Beth Rios, Moshe Talpaz

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α regimens for early chronic phase'. Together they form a unique fingerprint.

Medicine & Life Sciences